Literature DB >> 12056820

Histone deacetylase inhibition results in decreased macrophage CD9 expression.

Xue-Qing Wang1, M Leticia Alfaro, Glenn F Evans, Steven H Zuckerman.   

Abstract

Histone deacetylase (HDAC) inhibitors have been demonstrated to regulate myeloid cell differentiation. In the present study the effects of the HDAC inhibitor trichostatin A (TSA) on the tetraspanin cell surface antigen CD9 were determined in primary murine macrophages. TSA inhibited CD9 protein and message expression and was optimal by 48 h. TSA did not induce similar effects on other surface markers and resulted in a modest increase or no effect on CD54 and CD11b, respectively. These effects were concentration dependent and concomitant with increased histone H4 acetylation. While interferon-gamma (IFN-gamma) and TSA had similar effects on CD9 expression, transcriptional profiling demonstrated significant differences in the genes activated by these stimuli. Notably CD14 message was down-regulated by IFN-gamma while increased by TSA. These results demonstrate that HDAC inhibition may modulate macrophage function in part through changes in the expression of membrane proteins associated with matrix interactions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12056820     DOI: 10.1016/S0006-291X(02)00523-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse.

Authors:  Nilamadhab Mishra; Christopher M Reilly; Doris R Brown; Phil Ruiz; Gary S Gilkeson
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

2.  Expression and function of CD9 in melanoma cells.

Authors:  Jun Fan; Guo-Zhang Zhu; Richard M Niles
Journal:  Mol Carcinog       Date:  2010-01       Impact factor: 4.784

3.  HDAC3 is linked to cell cycle machinery in MiaPaCa2 cells by regulating transcription of skp2.

Authors:  G Schneider; M Reichert; D Saur; R Hamacher; R Fritsch; R M Schmid
Journal:  Cell Prolif       Date:  2007-08       Impact factor: 6.831

4.  Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene.

Authors:  Mark Ferguson; Patricia A Henry; R Alexander Currie
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

5.  ING2, a tumor associated gene, enhances PAI‑1 and HSPA1A expression with HDAC1 and mSin3A through the PHD domain and C‑terminal.

Authors:  Chiyo Ohkouchi; Kensuke Kumamoto; Motonobu Saito; Teruhide Ishigame; Shin-Ichi Suzuki; Seiichi Takenoshita; Cutis C Harris
Journal:  Mol Med Rep       Date:  2017-09-20       Impact factor: 2.952

Review 6.  Preclinical and clinical progress for HDAC as a putative target for epigenetic remodeling and functionality of immune cells.

Authors:  Sijia Zhang; Lingjun Zhan; Xue Li; Zhenhong Yang; Yumin Luo; Haiping Zhao
Journal:  Int J Biol Sci       Date:  2021-08-03       Impact factor: 6.580

7.  The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses.

Authors:  José Manuel Afonso Moreira; Peter Scheipers; Poul Sørensen
Journal:  BMC Cancer       Date:  2003-11-09       Impact factor: 4.430

8.  Statins decrease lung inflammation in mice by upregulating tetraspanin CD9 in macrophages.

Authors:  Yingji Jin; Isao Tachibana; Yoshito Takeda; Ping He; Sujin Kang; Mayumi Suzuki; Hanako Kuhara; Satoshi Tetsumoto; Kazuyuki Tsujino; Toshiyuki Minami; Takeo Iwasaki; Kaori Nakanishi; Satoshi Kohmo; Haruhiko Hirata; Ryo Takahashi; Koji Inoue; Izumi Nagatomo; Hiroshi Kida; Takashi Kijima; Mari Ito; Hideyuki Saya; Atsushi Kumanogoh
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.